{"id":"W2139026714","doi":"10.3324/haematol.11168","title":"Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial","year":2007,"lang":"en","type":"article","venue":"Haematologica","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Infection and Immunity; Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Melphalan; Multiple myeloma; Cyclophosphamide; Internal medicine; Total body irradiation; Regimen; Chemotherapy; Randomized controlled trial; Surgery; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00340629,0.0006939083,0.002203958,0.0002129284,0.0003559965,0.00100837,0.000668508,0.001295562,0.001816678],"category_scores_gemma":[0.002618137,0.0002847814,0.001634291,0.0003148132,0.0005661093,0.000551886,0.0003524527,0.001503541,0.0002076581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001002874,"about_ca_system_score_gemma":0.001196382,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001998298,"about_ca_topic_score_gemma":0.004592309,"domain_scores_codex":[0.9979544,0.001548713,0.00006231699,0.0001876463,0.00008521387,0.000161792],"domain_scores_gemma":[0.9980612,0.0005505924,0.0006519338,0.0001824312,0.00008862068,0.00046516],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9743339,0.001823825,0.00431665,0.0002624502,0.002428382,0.00003564276,0.00003242563,0.0004279899,0.0009033886,0.00007591448,0.0007233217,0.01463611],"study_design_scores_gemma":[0.8412418,0.1062919,0.0439513,0.0002136161,0.003681411,0.0001372203,0.00006461525,0.0008133735,0.0006420342,0.0004274578,0.002496072,0.00003917551],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892855,0.007935313,0.0001927578,0.0005231271,0.0001875705,0.0004181877,0.0004862185,0.00001337188,0.0009580356],"genre_scores_gemma":[0.9941048,0.00183611,0.0004277197,0.0006143493,0.0002201394,0.000721506,0.0008575706,0.000009516742,0.001208328],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00340629,"threshold_uncertainty_score":0.01801437,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06266984780719237,"score_gpt":0.3249320796119417,"score_spread":0.2622622318047493,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}